These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. State of the evidence: current status and prospects of meta-analysis in infectious diseases. Ioannidis JP; Lau J Clin Infect Dis; 1999 Nov; 29(5):1178-85. PubMed ID: 10524960 [TBL] [Abstract][Full Text] [Related]
3. Daily dosage of aminoglycosides. Urban AW; Craig WA Curr Clin Top Infect Dis; 1997; 17():236-55. PubMed ID: 9189668 [No Abstract] [Full Text] [Related]
4. Key pathogens and emerging therapies in infectious diseases. Miller PF; Mueller JP Curr Opin Pharmacol; 2009 Oct; 9(5):535-6. PubMed ID: 19766536 [No Abstract] [Full Text] [Related]
5. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011. Ter Meulen J Infect Dis Clin North Am; 2011 Dec; 25(4):789-802. PubMed ID: 22054756 [TBL] [Abstract][Full Text] [Related]
6. Systematic reviews and meta-analyses in infectious diseases: how are they done and what are their strengths and limitations? Leibovici L; Falagas ME Infect Dis Clin North Am; 2009 Jun; 23(2):181-94. PubMed ID: 19393904 [TBL] [Abstract][Full Text] [Related]
7. [20 years of antibiotics in the treatment of infectious diseases]. Therapiewoche; 1965 Sep; 15(18):975-9. PubMed ID: 5840228 [No Abstract] [Full Text] [Related]
9. [Modern antibiotics in the clinical picture of infectious diseases]. Bilibin AF; Il'inskiÄ IuA; Gracheva NM Antibiotiki; 1980 Aug; 25(8):615-9. PubMed ID: 7406473 [TBL] [Abstract][Full Text] [Related]
10. Introduction: infectious diseases in the critically ill. Olsen KM; Ng TM J Pharm Pract; 2010 Feb; 23(1):5. PubMed ID: 21507787 [No Abstract] [Full Text] [Related]
11. [Chemotherapy of infectious diseases 1966]. Riva G Praxis; 1967 Mar; 56(13):434-9. PubMed ID: 5631838 [No Abstract] [Full Text] [Related]
12. [The problem of the choice of antibiotics in infectious pathology]. Cairella M Clin Ter; 1970 Mar; 52(5):471-6. PubMed ID: 5421988 [No Abstract] [Full Text] [Related]
14. Back from the dead. Emerging and re-emerging infectious diseases. Cornell S Adv Nurse Pract; 1998 May; 6(5):67-8. PubMed ID: 9633297 [No Abstract] [Full Text] [Related]
15. Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials. Potashman MH; Formella DN; Hamed K; Mohr JF J Antimicrob Chemother; 2015 Apr; 70(4):1274-5. PubMed ID: 25583745 [No Abstract] [Full Text] [Related]
17. [Trials with a new combination preparation for the treatment of microbial infectious diseases]. Buser E Schweiz Arch Tierheilkd; 1968 Nov; 110(11):673-81. PubMed ID: 5753486 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials-authors' response. He W; Wang H J Antimicrob Chemother; 2015 Apr; 70(4):1275. PubMed ID: 25583747 [No Abstract] [Full Text] [Related]
19. [The treatment of infectious conjunctivitis]. Kamilov M Oftalmol Zh; 1968; 23(3):183-6. PubMed ID: 5733334 [No Abstract] [Full Text] [Related]